Filing search / Kineta, Inc. / "Supplier"

Search information

Kineta, Inc.

Companies

"Supplier"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

28 results

Newest first Best match first

collaborator or supplier be interrupted, delayed or otherwise be unavailable to Kineta, Kineta’s clinical trials may be delayed. In the event Kineta … were to experience an unexpected loss of supply of or if any supplier were unable to meet Kineta’s clinical or commercial demand for any of Kineta’s

21 Mar 24

4:06pm

the supply of products from any collaborator or supplier be interrupted, delayed or otherwise be unavailable to Kineta, Kineta’s clinical trials may … of or if any supplier were unable to meet Kineta’s clinical or commercial demand for any of Kineta’s product candidates, Kineta could experience delays in its

31 Mar 23

4:05pm

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

the supply of products from any collaborator or supplier be interrupted, delayed or otherwise be unavailable to Kineta, Kineta’s clinical trials may … supplier were unable to meet Kineta’s clinical or commercial demand for any of Kineta’s product candidates, Kineta could experience delays in its

424B3

KANT Kineta, Inc.

10 Nov 22

Prospectus supplement

4:21pm

. Additionally, should the supply of products from any collaborator or supplier be interrupted, delayed or otherwise be unavailable to Kineta, Kineta’s … supplier were unable to meet Kineta’s clinical or commercial demand for any of Kineta’s product candidates, Kineta could experience delays in its planned

S-4/A

KANT Kineta, Inc.

Registration of securities issued in business combination transactions (amended)

from any collaborator or supplier be interrupted, delayed or otherwise be unavailable to Kineta, Kineta’s clinical trials may be delayed. In the event … development or marketing approval. If Kineta were to experience an unexpected loss of supply of or if any supplier were unable to meet Kineta’s clinical

4 Nov 22

4:49pm

S-4/A

kqcmv7

Registration of securities issued in business combination transactions (amended)

24 Oct 22

9:14am

S-4/A

EX-10.52

w65ljgqe6

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

S-4/A

ipnyv5qeo2ayi4ur73

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

S-4/A

EX-10.65

g5az4d8h

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

S-4

q5u3yovzkkugm3h9l

Registration of securities issued in business combination transactions

29 Aug 22

12:00am

425

xvtgpr1375t

6 Jun 22

Business combination disclosure

Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions

Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions

3 Dec 21

4:15pm

Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants

12 Aug 21

4:23pm

12 Aug 21

4:23pm

Entry into a Material Definitive Agreement

Yumanity Therapeutics and Proteostasis Therapeutics Announce

Business combination disclosure

5:28pm

Filing search / Kineta, Inc. / "Supplier"

28 results

Top filers

Top filing types

Recent filing years